Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations. Zepbound sales reached $1.9 billion in ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Is Compounded Semaglutide Effective for Weight Loss? This article was reviewed ... What about tirzepatide (Mounjaro and Zepbound) GLP-1 receptor agonists? Our blog compares tirzepatide versus ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with competitor Eli Lilly’s Zepbound.

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing ...

For Zepbound’s 10mg weekly dose, the average weight loss was 22.2 kg (48.9 lb), and for Zepbound’s 15mg weekly dose average weight loss was 23.6 kg (52.0 lb) over 72 weeks. Patients who used a ...

"CO2 in carbonated water may promote weight loss by enhancing glucose uptake and metabolism in red blood cells," according to researchers Getty Plain seltzer water may give you a weight-loss ...

Doctors warn about their physical side effects, but they can also have unexpected effects on intimacy. Jeanne and Javier, who have been married for 15 years.Credit...Katherine Wolkoff for The New ...

GLP-1 drugs used for weight ... loss—although not all are expressly approved for this purpose—include Ozempic and Wegovy (semaglutide), Victoza and Saxenda (liraglutide), and Mounjaro and ...

Feb. 10, 2025 — Rapid weight loss affects muscle mass and can increase the risk of osteoporosis. But now there is good news for people taking weight loss medication who may be at risk.